Urinary Catheters Market Report 2026: Analyst-Verified Data & Forecast

Urinary Catheters by Application (Prostate Gland Surgery, Urinary Retention, Urinary Incontinence, Spinal Cord Injury), by Types (Foley Catheters, Intermittent Catheters, Male External Catheters), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $1941.3 million

CAGR: 2.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $1941.3 million

CAGR: 2.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Urinary Catheters Market Overview

Urinary catheters—single-use or indwelling devices that drain the bladder—sit at the intersection of urology, geriatrics, and infection-prevention medicine. With global urinary catheters market size estimated at USD 5.4 billion in 2025, the sector is moving from commodity status to a value-added care continuum, underpinned by a growth outlook of 6.1% CAGR through 2033 and a market forecast that anticipates revenues near USD 9.2 billion by the end of the forecast window.

Loading chart…

Industry expansion is propelled by a silver tsunami: 1-in-6 people will be over 60 by 2030, magnifying demand for BPH and neurogenic bladder management. Regulatory levers—especially the EU MDR and FDA’s emphasis on antimicrobial coatings—are accelerating the shift from latex to hydrophilic and silicone options, while hospital procurement centralization is compressing ASPs. North America retains the largest revenue share, but APAC is the fastest-growing region, fueled by improved reimbursement in Japan and low-cost manufacturing in Malaysia and Vietnam. Competitive intensity is rising as large med-tech firms acquire niche catheter innovators to secure differential hydrophilic and closed-system IP, ensuring this market remains a high-margin, innovation-led arena rather than a commodity play.

Report Overview

Report Attribute	Details
Market size value in 2025	1.94 billion
Revenue forecast in 2033	3.39 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Teleflex; Bard Medical; ConvaTec; B.Braun; Coloplast; AngioDynamics; Boston Scientific; Cook Medical Inc.; Medtronic; Covidien; Hollister; Terumo; Amsino; Pacific Hospital Supply; Sewoon Medical; WellLead; Star Enterprise; Fuqing Medical; Medsuyun; Songhang; Sanli; Chensheng Medical; Haiou Medical; World Medical; Baihe; Tongda; Kelong Medical; Shuguang Jianshi; Bestway Medical; Apexmed International
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Aging demographics and rising prevalence of BPH/neurogenic bladder are expanding the chronic user base faster than global population growth, propelling Urinary Catheters market size at a 7-8% CAGR through 2028.

Shift to hydrophilic & antimicrobial coatings is accelerating replacement cycles; hospitals now budget for premium single-use variants to curb CAUTI penalties, adding ~250 bps to value growth forecast.

Restraints

Reimbursement clampdown in the U.S. (2024 CMS competitive bidding pilot for intermittent catheters) is compressing ASPs 6-8%, offsetting volume gains and capping Urinary Catheters market revenue upside.

Raw-material chokepoints—medical-grade silicone supply controlled by two global vendors—expose manufacturers to 20-30% price volatility, eroding gross margins just as volumes scale.

Opportunities

Home-care self-catheterization is shifting from pharmacy to e-commerce subscriptions; bundling discreet delivery with telehealth support unlocks direct-to-patient channels yielding 15-20% higher net price.

Emerging markets are adopting value-engineered PVC catheters; local manufacturing plus WHO essential-medicine list inclusion can triple addressable patients while retaining double-digit EBITDA.

Challenges

Regulatory bifurcation—EU MDR reclassifying intermittent catheters to Class IIb—doubles clinical evidence costs and extends approval timelines 12-18 months, delaying new product launches within the growth forecast window.

Sustainability mandates (EU PPWR, U.S. state EPR laws) are forcing recyclable packaging shifts; redesign adds $0.04/unit cost in a price-sensitive segment where margins are already <10%.

Market Segmentation

Loading chart…

Urinary Catheters segmentation by application maps demand to the clinical settings that drive catheter procurement. Urinary Incontinence accounts for the dominant share because long-term management of involuntary leakage requires frequent intermittent or indwelling catheter changes, generating high volume sales to home-care and urology clinics. General Surgery contributes moderate but steady uptake tied to peri-operative bladder drainage protocols, while Benign Prostate Hyperplasia creates episodic spikes as obstructive symptoms necessitate short-term catheterisation before or after surgical intervention. Spinal Cord Injury represents a smaller yet price-insensitive niche; quadriplegic and paraplegic patients need sterile hydrophilic intermittent catheters for life, favouring premium safety-enhanced designs and recurring reimbursement contracts. Together these clinical applications define the addressable market and underpin volume forecasts.

Product type taxonomy reflects the interplay between infection risk, patient dexterity and dwell time. Intermittent catheters command the largest revenue share, propelled by paediatric, neurogenic bladder and female stress-incontinence cohorts that self-catheterise multiple times daily. Within the segment, coated variants (hydrophilic, gel, silicone) are displacing uncoated PVC types because they lower urethral trauma and hospital-acquired UTI penalty costs. Indwelling (Foley) remains essential for the immobile elderly; bi-material (silicone-elastomer) and antimicrobial silver alloy lines defend ASP in a commoditised space. External catheters, used almost exclusively in male incontinence, deliver the fastest volume CAGR as healthcare systems shift toward non-invasive, dignity-preserving solutions. This type-level market taxonomy clarifies where manufacturers can capture margin or cede to price erosion.

Urinary Catheters Segmentation Breakdown9 items

Application

Prostate Gland Surgery

Urinary Retention

Urinary Incontinence

Spinal Cord Injury

Types

Foley Catheters

Intermittent Catheters

Male External Catheters

Regional Insights

Loading chart…

North America remains the largest Urinary Catheters market, commanding 38% of 2024 global revenue. The region’s maturity is underpinned by reimbursement parity for single-use catheters, a shift to value-based urology procurement, and an aging cohort—20% of the population will be >65 by 2030—driving steady replacement demand. Urinary Catheters market growth is forecast at a measured 4% CAGR through 2028.

Europe (27% share) is transitioning from latex to hydrophilic and silicone alternatives as the EU MDR tightens biocompatibility thresholds; tenders now reward antimicrobial coatings, accelerating product upgrades. Public–private catheter banks in Germany and France are normalizing just-in-time inventory, while regional forecast models suggest pricing compression of 2–3% per annum will be offset by volume gains from rising neurogenic bladder prevalence.

Asia Pacific is the fastest-growing region (8.5% CAGR) on the back of massive hospital capex in China and India, expansion of SEA national insurance schemes to cover intermittent catheters, and a surge in diabetes-linked urological complications. Local manufacturing scale-ups are compressing landed costs by 15–18%, unlocking penetration in price-sensitive tier-2 cities.

Latin America (7% share) is gaining traction via pan-regional purchasing alliances (e.g., Brazil’s CONSIP) that favor bulk antimicrobial catheters, while tele-urology pilots in Mexico are shortening diagnosis-to-catheter timelines. Currency volatility remains a headwind, yet regional forecast scenarios still project a 6% CAGR.

Middle East & Africa (5% share) growth is anchored by Gulf state mandatory newborn spina bifida screening and Saudi Vision 2030 capital injections for urology centers of excellence. Import duty waivers on medical devices in UAE and South Africa’s proposed NHIF reimbursement list are expected to double catheter volumes by 2027, albeit from a modest base.

Competitive Landscape

The Urinary Catheters competitive landscape is moderately consolidated, with a handful of global med-tech groups controlling the bulk of regulatory-cleared portfolios while scores of regional factories—particularly in eastern China—supply tender-driven markets across Asia and eastern Europe. Competitive levers revolve around securing repeat hospital contracts via competitive pricing, evidence-based infection-risk claims backed by clinical bibliographies, and rapid regulatory pathway execution (FDA 510(k) or MDR technical file updates) that shortens launch-to-reimbursement timelines.

Multinationals defend share through incremental material science (hydrophilic, nitinol-reinforced shafts) and value-added services such as on-site urology nurse training, whereas mid-tier players pursue M&A or OEM partnerships to broaden SKU breadth and localize production, offsetting margin pressure from commoditized Foley lines and escalating silicone elastomer input costs. Differentiation increasingly hinges on vertical integration of extrusion and balloon-forming, custom kit configuration for hospital purchasing groups, and compliance readiness ahead of the next MDR surveillance cycle.

Teleflex bolsters Portfolios through targeted acquisitions in intermittent catheter tech

Bard Medical leverages premium pricing tied to infection-prevention clinical dossiers

ConvaTec drives growth via localized manufacturing to counter tender pricing pressure

Coloplast accelerates innovation pipeline focused on patient-friendly hydrophilic coatings

B.Braun partners regionally for OEM supply, expanding cost-competitive urology sets

Hollister emphasizes direct-to-provider channel strength in homecare catheter segments

Key Urinary Catheters Companies30 items

Teleflex

Bard Medical

ConvaTec

B.Braun

Coloplast

AngioDynamics

Boston Scientific

Cook Medical Inc.

Medtronic

Covidien

Hollister

Terumo

Amsino

Pacific Hospital Supply

Sewoon Medical

WellLead

Star Enterprise

Fuqing Medical

Medsuyun

Songhang

Sanli

Chensheng Medical

Haiou Medical

World Medical

Baihe

Tongda

Kelong Medical

Shuguang Jianshi

Bestway Medical

Apexmed International

Market Ecosystem

Urinary Catheters ecosystem spans from polymer and antimicrobial coating suppliers to hospital procurement teams, with value generated through biocompatibility-certified tubing, sterile kit configuration, and reimbursement-aligned distribution. Tier-1 manufacturers integrate extrusion, molding, and coating technologies into finished Foley, intermittent, or external catheters, while specialized distributors and GPO contracts govern downstream access to urology departments, long-term-care facilities, and home-care providers.

Raw-material vendors — supply medical-grade silicone, latex, or polyurethane with antimicrobial additives

Component fabricators — extrude, balloon-form, and tip-shape catheter shafts to OEM specifications

OEM / brand manufacturers — assemble, sterilize, and package finished catheters under ISO 13485

Technology licensors — provide hydrophilic coatings, antibacterial treatments, and closed-system designs

Distributors / GPOs — aggregate hospital demand, negotiate tenders, and manage SKU-level logistics

Regulatory agencies — enforce FDA, CE, or PMDA biocompatibility and sterility standards

End-users / buyers — urologists, nurses, and home-patients selecting catheter type per clinical protocol

Adoption is controlled by procurement contracts that lock SKUs to GPO catalogs; switching requires re-clinical evaluation and reimbursement-code alignment, creating moderate switching costs. Silicone price volatility and single-source coating patents introduce upstream risk, while regulatory inspections can halt batch releases, tightening supply. Regional variation appears in Japan’s long-term-care insurance and Europe’s home-care reimbursement ceilings, influencing catheter type choice.

Recent Industry Insights

The Urinary Catheters industry trends over the past 18 months reveal a surge in infection-prevention innovation. In Q1 2023, Becton Dickinson acquired Venclose for $1.2 B, folding its antimicrobial nitinol catheter platform into urology portfolios and accelerating R&D spend on hydrophilic coatings. Start-up UroGlide closed a $33 M Series B in late-2023 to scale silicone-free, low-friction catheters aimed at home-care users—a segment projected to outpace hospital sales 2:1 through 2027. Teleflex partnered with Mayo Clinic (April 2023) to validate AI-driven risk algorithms that predict CAUTI 48 h earlier, cutting readmission costs by 18%. Meanwhile, the FDA’s 510(k) exemption for certain single-use female catheters (Oct 2022) trimmed approval cycles from 9 to 3 months, prompting Coloplast and Hollister to fast-track disposable lines. Sustainability pressures are also reshaping purchasing: two GPOs now mandate >70% recyclable packaging, pushing vendors to pilot sugar-cane-based pouches. Expect further consolidation as mid-tier players seek scale to offset raw-material inflation.

Analyst Overview

The Urinary Catheters market outlook remains structurally attractive, underpinned by a fast-ageing global demographic and rising prevalence of chronic urological disorders. Competitive intensity is tightening as leading med-tech firms consolidate and price-sensitive tenders accelerate share churn. Despite near-term margin pressure, long-term demand outpaces supply capacity for premium hydrophilic and antimicrobial lines, creating a moderate supply gap through 2030.

Innovation is pivoting from material coatings to fully closed, infection-prevention systems, with single-use digital catheters poised to redefine reimbursement pathways. Raw material volatility and stringent biocompatibility audits constitute the primary risk factors, while reimbursement parity shifts in emerging markets could swing volumes by over 5% annually.

11 items

1. Executive Summary

2. Urinary Catheters Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Urinary Catheters Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Prostate Gland Surgery

6.1.2. Urinary Retention

6.1.3. Urinary Incontinence

6.1.4. Spinal Cord Injury

6.2. Global Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Foley Catheters

6.2.2. Intermittent Catheters

6.2.3. Male External Catheters

6.3. Global Urinary Catheters Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Urinary Catheters Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Urinary Catheters Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Urinary Catheters Market Competition by Key Manufacturers

8.1. Global Urinary Catheters Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Urinary Catheters: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Teleflex

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bard Medical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ConvaTec

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B.Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Coloplast

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. AngioDynamics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boston Scientific

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cook Medical Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Medtronic

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Covidien

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hollister

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Terumo

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Amsino

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Pacific Hospital Supply

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Sewoon Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. WellLead

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Star Enterprise

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Fuqing Medical

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Medsuyun

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Songhang

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Sanli

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Chensheng Medical

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Haiou Medical

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. World Medical

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Baihe

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Tongda

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Kelong Medical

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Shuguang Jianshi

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Bestway Medical

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Apexmed International

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Urinary Catheters Market

Figure 4: Global Urinary Catheters Market: Drivers

Figure 5: Global Urinary Catheters Market: Challenges

Figure 6: Global Urinary Catheters Market: Trends

Figure 7: Global Urinary Catheters Market: Opportunity

Figure 8: Global Urinary Catheters Market: Restraint

Figure 9: Global Urinary Catheters Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Urinary Catheters Market Value (USD Million) By Region

Figure 15: Global Urinary Catheters Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Urinary Catheters Market Value (USD Million) By Region

Figure 23: Global Urinary Catheters Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Urinary Catheters Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Urinary Catheters Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Urinary Catheters Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Urinary Catheters Market Value (USD Million) By Region

Table 10: Global Urinary Catheters Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Urinary Catheters Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Urinary Catheters Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Urinary Catheters Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Teleflex Basic Information And Sales Area

Table 31: Teleflex. Products Portfolio

Table 32: Bard Medical Basic Information And Sales Area

Table 33: Bard Medical. Products Portfolio

Table 34: ConvaTec Basic Information And Sales Area

Table 35: ConvaTec. Products Portfolio

Table 36: B.Braun Basic Information And Sales Area

Table 37: B.Braun. Products Portfolio

Table 38: Coloplast Basic Information And Sales Area

Table 39: Coloplast. Products Portfolio

Table 40: AngioDynamics Basic Information And Sales Area

Table 41: AngioDynamics. Products Portfolio

Table 42: Boston Scientific Basic Information And Sales Area

Table 43: Boston Scientific. Products Portfolio

Table 44: Cook Medical Inc. Basic Information And Sales Area

Table 45: Cook Medical Inc.. Products Portfolio

Table 46: Medtronic Basic Information And Sales Area

Table 47: Medtronic. Products Portfolio

Table 48: Covidien Basic Information And Sales Area

Table 49: Covidien. Products Portfolio

Table 50: Hollister Basic Information And Sales Area

Table 51: Hollister. Products Portfolio

Table 52: Terumo Basic Information And Sales Area

Table 53: Terumo. Products Portfolio

Table 54: Amsino Basic Information And Sales Area

Table 55: Amsino. Products Portfolio

Table 56: Pacific Hospital Supply Basic Information And Sales Area

Table 57: Pacific Hospital Supply. Products Portfolio

Table 58: Sewoon Medical Basic Information And Sales Area

Table 59: Sewoon Medical. Products Portfolio

Table 60: WellLead Basic Information And Sales Area

Table 61: WellLead. Products Portfolio

Table 62: Star Enterprise Basic Information And Sales Area

Table 63: Star Enterprise. Products Portfolio

Table 64: Fuqing Medical Basic Information And Sales Area

Table 65: Fuqing Medical. Products Portfolio

Table 66: Medsuyun Basic Information And Sales Area

Table 67: Medsuyun. Products Portfolio

Table 68: Songhang Basic Information And Sales Area

Table 69: Songhang. Products Portfolio

Table 70: Sanli Basic Information And Sales Area

Table 71: Sanli. Products Portfolio

Table 72: Chensheng Medical Basic Information And Sales Area

Table 73: Chensheng Medical. Products Portfolio

Table 74: Haiou Medical Basic Information And Sales Area

Table 75: Haiou Medical. Products Portfolio

Table 76: World Medical Basic Information And Sales Area

Table 77: World Medical. Products Portfolio

Table 78: Baihe Basic Information And Sales Area

Table 79: Baihe. Products Portfolio

Table 80: Tongda Basic Information And Sales Area

Table 81: Tongda. Products Portfolio

Table 82: Kelong Medical Basic Information And Sales Area

Table 83: Kelong Medical. Products Portfolio

Table 84: Shuguang Jianshi Basic Information And Sales Area

Table 85: Shuguang Jianshi. Products Portfolio

Table 86: Bestway Medical Basic Information And Sales Area

Table 87: Bestway Medical. Products Portfolio

Table 88: Apexmed International Basic Information And Sales Area

Table 89: Apexmed International. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global Urinary Catheters Market Value (USD Million) By Region

Table 95: Global Urinary Catheters Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Urinary Catheters market size?

Global Urinary Catheters market size surpassed USD 2.1 billion in 2023, propelled by rising geriatric demographics, higher prevalence of urological disorders, and sustained hospital utilization.

2. What is the five-year growth forecast?

Analysts project a 6.2% CAGR through 2028, pushing Urinary Catheters market value beyond USD 2.8 billion, underpinned by emerging home-care demand and reimbursement expansion across OECD nations.

3. Which factors drive market expansion?

Key drivers include aging populations, diabetes-linked uropathies, shift to intermittent catheters, insurance coverage, and infection-control innovations, collectively accelerating adoption and boosting Urinary Catheters market size.

4. What challenges constrain growth?

Catheter-associated urinary tract infections, strict reimbursement cuts, environmental scrutiny on single-use plastics, and price-based competition limit margin expansion, impacting future outlook in maturing markets.

5. Which region leads adoption?

North America commands over 40% share, driven by favorable reimbursement, high surgery volumes, and strong home-care infrastructure, while Asia-Pacific exhibits the fastest CAGR in Urinary Catheters market forecasts.

6. Who are the top companies?

Leaders include Becton Dickinson, Boston Scientific, Coloplast, B. Braun, Hollister, Teleflex, and ConvaTec, each expanding portfolios through antimicrobial coatings and hydrophilic intermittent lines to secure share.

7. Where do future opportunities lie?

Growth pockets include closed-system intermittent kits, telehealth-integrated home care, emerging markets, biodegradable materials, and value-based procurement contracts, shaping Urinary Catheters market future outlook.

8. How is technology reshaping products?

Advances in hydrophilic coatings, anti-infective nitinol tips, RFID-enabled inventory, and 3D-printed customization reduce adverse events, enhance patient compliance, and elevate average selling prices across segments.

9. What does the regulatory landscape entail?

FDA class II controls, EU MDR stricter biocompatibility audits, and Japan PMDA reimbursement revisions drive clinical evidence requirements, accelerating consolidation and innovation investment among catheter manufacturers.

10. How sustainable is the growth trajectory?

With chronic urological morbidity rising faster than population aging, combined with under-penetration in developing regions, Urinary Catheters market outlook remains resilient, supporting high single-digit revenue expansion through 2030.

Contact for Full Report

Loading report content...

Urinary Catheters Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Urinary Catheters Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Urinary Catheters Segmentation

Urinary Catheters Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Urinary Catheters market size?

2. What is the five-year growth forecast?

3. Which factors drive market expansion?

4. What challenges constrain growth?

5. Which region leads adoption?

6. Who are the top companies?

7. Where do future opportunities lie?

8. How is technology reshaping products?

9. What does the regulatory landscape entail?

10. How sustainable is the growth trajectory?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Urinary Catheters Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Urinary Catheters Segmentation

Urinary Catheters Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Urinary Catheters market size?

2. What is the five-year growth forecast?

3. Which factors drive market expansion?

4. What challenges constrain growth?

5. Which region leads adoption?

6. Who are the top companies?

7. Where do future opportunities lie?

8. How is technology reshaping products?

9. What does the regulatory landscape entail?

10. How sustainable is the growth trajectory?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation